Nirogacestat is approved by the FDA for treating rare non-cancerous soft tissue sarcomas.

Published Date: 01 Dec 2023

The USA. s. For adult patients who need nirogacestat (Ogsiveo) due to their desmoid tumors progressing, the Food and Drug Administration has approved the tablets.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Nirogacestat is approved by the FDA for treating rare non-cancerous soft tissue sarcomas.

2.

Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?

3.

How to keep your prostate healthy and lower your risk of developing serious problems

4.

Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training

5.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot